Cytoprotective Effects of Mesenchymal Stem Cells During Liver Transplantation from Donors After Cardiac Death in Rats.

[1]  J. Calderaro,et al.  An Oxygenated and Transportable Machine Perfusion System Fully Rescues Liver Grafts Exposed to Lethal Ischemic Damage in a Pig Model of DCD Liver Transplantation , 2017, Transplantation.

[2]  Yi-tao Ding,et al.  Intraportal mesenchymal stem cell transplantation prevents acute liver failure through promoting cell proliferation and inhibiting apoptosis. , 2016, Hepatobiliary & pancreatic diseases international : HBPD INT.

[3]  Yan Wang,et al.  Mesenchymal stem cells improve mouse non-heart-beating liver graft survival by inhibiting Kupffer cell apoptosis via TLR4-ERK1/2-Fas/FasL-caspase3 pathway regulation , 2016, Stem Cell Research & Therapy.

[4]  Yuehui Ma,et al.  Identification and characterization of pig adipose-derived progenitor cells. , 2016, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.

[5]  N. Ohuchi,et al.  Resveratrol Prevents Warm Ischemia-Reperfusion Injury in Liver Grafts From Non-Heart-Beating Donor Rats. , 2016, Transplantation proceedings.

[6]  Kazama Tomohiko,et al.  Basic Research and Clinical Application in Mesenchymal Stem Cells , 2016 .

[7]  F. Jouret,et al.  Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury , 2015, Journal of immunology research.

[8]  Weijie Wang,et al.  Mesenchymal Stem Cells Promote Liver Regeneration and Prolong Survival in Small-For-Size Liver Grafts: Involvement of C-Jun N-Terminal Kinase, Cyclin D1, and NF-κB , 2014, PloS one.

[9]  N. Ohuchi,et al.  Edaravone, a free radical scavenger, improves the graft viability on liver transplantation from non-heart-beating donors in pigs. , 2014, Transplantation proceedings.

[10]  P. Morel,et al.  Transplantation of mesenchymal stem cells for the treatment of liver diseases, is there enough evidence? , 2013, Stem cell research.

[11]  Jiqi Yan,et al.  Mesenchymal stem cell-conditioned medium reduces liver injury and enhances regeneration in reduced-size rat liver transplantation. , 2013, The Journal of surgical research.

[12]  K. Wood,et al.  Mesenchymal stromal cells in transplantation rejection and tolerance. , 2013, Cold Spring Harbor perspectives in medicine.

[13]  M. Seifert,et al.  Ischemia–reperfusion injury: beneficial effects of mesenchymal stromal cells , 2013, Current opinion in organ transplantation.

[14]  Pengcheng Zhou,et al.  Immediate intraportal transplantation of human bone marrow mesenchymal stem cells prevents death from fulminant hepatic failure in pigs , 2012, Hepatology.

[15]  Lanjuan Li,et al.  Therapeutic potential of transplanted placental mesenchymal stem cells in treating Chinese miniature pigs with acute liver failure , 2012, BMC Medicine.

[16]  T. Liang,et al.  Mesenchymal stem cells administered after liver transplantation prevent acute graft‐versus‐host disease in rats , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[17]  E. Yannaki,et al.  Mesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis , 2012, Annals of the rheumatic diseases.

[18]  A. Pileggi.  Mesenchymal Stem Cells for the Treatment of Diabetes , 2012, Diabetes.

[19]  G. Kazemier,et al.  Secreted factors of human liver-derived mesenchymal stem cells promote liver regeneration early after partial hepatectomy. , 2012, Stem cells and development.

[20]  De-sheng Wang,et al.  Intravenous injection of mesenchymal stem cells is effective in treating liver fibrosis. , 2012, World journal of gastroenterology.

[21]  S. Uemoto,et al.  Bone Marrow-Derived Mesenchymal Stem Cells Ameliorate Hepatic Ischemia Reperfusion Injury in a Rat Model , 2011, PloS one.

[22]  Liyong Pu,et al.  Antifibrotic effect of hepatocyte growth factor-expressing mesenchymal stem cells in small-for-size liver transplant rats. , 2010, Stem cells and development.

[23]  Xiaodong Chen,et al.  Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair , 2010, Cell Research.

[24]  O. Podhajcer,et al.  Mesenchymal stem cells as therapeutic tools and gene carriers in liver fibrosis and hepatocellular carcinoma , 2010, Gene Therapy.

[25]  N. Perico,et al.  Toward MSC in Solid Organ Transplantation: 2008 Position Paper of the MISOT Study Group , 2009, Transplantation.

[26]  S. Fan,et al.  Antiinflammatory properties of IL‐10 rescue small‐for‐size liver grafts , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[27]  A. Caplan,et al.  Mesenchymal stem cells as trophic mediators , 2006, Journal of cellular biochemistry.

[28]  T. Minor,et al.  The isolated perfused rat liver: standardization of a time-honoured model , 2006, Laboratory animals.

[29]  N. Ohkohchi,et al.  EFFECTS OF ANTI-INFLAMMATORY CYTOKINE AGENT (FR167653) AND SERINE PROTEASE INHIBITOR ON WARM ISCHEMIA-REPERFUSION INJURY OF THE LIVER GRAFT , 2004, Transplantation.

[30]  T. Starzl.  The “privileged” liver and hepatic tolerogenicity , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[31]  R. Calne.  Immunological tolerance: the liver effect , 2002, Immunological reviews.

[32]  N. Ohkohchi,et al.  Assessment of viability of the liver graft in different cardiac arrest models. , 2000, Transplantation proceedings.

[33]  N. Ohkohchi,et al.  Elimination of Kupffer cells and nafamostat mesilate rinse prevent reperfusion injury in liver grafts from agonal non-heart-beating donors. , 1999, Transplantation.

[34]  H. Jahr,et al.  [The liver--an immunologically privileged organ?]. , 1989, Allergie und Immunologie.

[35]  R. Binns,et al.  Observations of orthotopic liver transplantation in the pig. , 1967, British medical journal.